Dacetuzumab (SGN-40), Lenalidomide, and Weekly Dexamethasone in Relapsed or Refractory Multiple Myeloma: Multiple Responses Observed in a Phase 1b Study.

Edward Agura; Ruben Niesvizky; Jeffrey Matous; Nikhil Munshi; Mohamad Hussein; Ramakrishnan V Parameswaran; Stefano Tarantolo; Nancy C Whiting; Jonathan G Drachman; Jeffrey A Zonder

doi:10.1182/BLOOD.V114.22.2870.2870

Dacetuzumab (SGN-40), Lenalidomide, and Weekly Dexamethasone in Relapsed or Refractory Multiple Myeloma: Multiple Responses Observed in a Phase 1b Study.

Edward Agura
, Ruben Niesvizky
, Jeffrey Matous
, Nikhil Munshi
, Mohamad Hussein
, Ramakrishnan V Parameswaran
, Stefano Tarantolo
, Nancy C Whiting
, Jonathan G Drachman
, Jeffrey A Zonder

Baylor University
Cornell University
Rocky Mountain Cancer Center, Denver, CO, USA,
Harvard University
The Cancer Institute of New Jersey, New Brunswick, NJ, USA,
Avera Cancer Institute, Sioux Falls, SD, USA,
Houston Methodist Hospital
Seattle Genetics
Wayne State University

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Blood
Volume	114
Issue number	22
DOIs	https://doi.org/10.1182/BLOOD.V114.22.2870.2870
State	Published - Nov 20 2009
Externally published	Yes

Disciplines

Immunology and Infectious Disease
Medicine and Health Sciences
Internal Medicine

Access to Document

10.1182/BLOOD.V114.22.2870.2870License: Unspecified

Cite this

Agura, E., Niesvizky, R., Matous, J., Munshi, N., Hussein, M., Parameswaran, R. V., Tarantolo, S., Whiting, N. C., Drachman, J. G., & Zonder, J. A. (2009). Dacetuzumab (SGN-40), Lenalidomide, and Weekly Dexamethasone in Relapsed or Refractory Multiple Myeloma: Multiple Responses Observed in a Phase 1b Study. Blood, 114(22). https://doi.org/10.1182/BLOOD.V114.22.2870.2870

@article{9265186988594f80a27043b104b41408,

title = "Dacetuzumab (SGN-40), Lenalidomide, and Weekly Dexamethasone in Relapsed or Refractory Multiple Myeloma: Multiple Responses Observed in a Phase 1b Study.",

author = "Edward Agura and Ruben Niesvizky and Jeffrey Matous and Nikhil Munshi and Mohamad Hussein and Parameswaran, \{Ramakrishnan V\} and Stefano Tarantolo and Whiting, \{Nancy C\} and Drachman, \{Jonathan G\} and Zonder, \{Jeffrey A\}",

note = "Edward Agura, Ruben Niesvizky, Jeffrey Matous, Nikhil Munshi, Mohamad Hussein, Ramakrishnan V Parameswaran, Stefano Tarantolo, Nancy C Whiting, Jonathan G Drachman, Jeffrey A Zonder; Dacetuzumab (SGN-40), Lenalidomide, and Weekly Dexamethasone in Relapsed or Refractory Multiple Myeloma: Multiple Responses Observed in a Phase 1b Study.. 2009; 114 (22): 2870.",

year = "2009",

month = nov,

day = "20",

doi = "10.1182/BLOOD.V114.22.2870.2870",

language = "American English",

volume = "114",

journal = "Blood",

publisher = "American Society of Hematology",

number = "22",

}

TY - JOUR

T1 - Dacetuzumab (SGN-40), Lenalidomide, and Weekly Dexamethasone in Relapsed or Refractory Multiple Myeloma: Multiple Responses Observed in a Phase 1b Study.

AU - Agura, Edward

AU - Niesvizky, Ruben

AU - Matous, Jeffrey

AU - Munshi, Nikhil

AU - Hussein, Mohamad

AU - Parameswaran, Ramakrishnan V

AU - Tarantolo, Stefano

AU - Whiting, Nancy C

AU - Drachman, Jonathan G

AU - Zonder, Jeffrey A

N1 - Edward Agura, Ruben Niesvizky, Jeffrey Matous, Nikhil Munshi, Mohamad Hussein, Ramakrishnan V Parameswaran, Stefano Tarantolo, Nancy C Whiting, Jonathan G Drachman, Jeffrey A Zonder; Dacetuzumab (SGN-40), Lenalidomide, and Weekly Dexamethasone in Relapsed or Refractory Multiple Myeloma: Multiple Responses Observed in a Phase 1b Study.. 2009; 114 (22): 2870.

PY - 2009/11/20

Y1 - 2009/11/20

UR - https://ashpublications.org/blood/article/114/22/2870/132143/Dacetuzumab-SGN-40-Lenalidomide-and-Weekly

U2 - 10.1182/BLOOD.V114.22.2870.2870

DO - 10.1182/BLOOD.V114.22.2870.2870

M3 - Article

VL - 114

JO - Blood

JF - Blood

IS - 22

ER -

Dacetuzumab (SGN-40), Lenalidomide, and Weekly Dexamethasone in Relapsed or Refractory Multiple Myeloma: Multiple Responses Observed in a Phase 1b Study.

Disciplines

Access to Document

Other files and links

Cite this